News & Media
About Abiomed and Impella® Heart Pumps
Based in Danvers, Massachusetts, USA, Abiomed, Inc. (NASDAQ: ABMD) is a leading provider of medical devices that provide circulatory and respiratory support. Our cardiac products are designed to enable the heart to rest and recover by improving blood flow and/or performing the pumping of the heart. Our easy-to-use respiratory product is designed to oxygenate the blood, while promoting mobility.
Impella heart pumps are the only U.S. Food and Drug Administration-approved percutaneous heart pump technology indicated for patients with severe coronary artery disease requiring high-risk PCI or treatment of AMI cardiogenic shock. Impella has the unique ability to enable your heart to recover, allowing patients to return home from the hospital with their native hearts.
Featured News
Media Center for Journalists
Abiomed’s media kit provides a comprehensive source of information for you to tell your story, from product images to b-roll video.
Explore the unique stories of people with complex heart disease and advanced heart failure who were able to recover their own hearts.
Contact Us
Tom Langford
Director of Communication
ABIOMED, Inc.
22 Cherry Hill Drive | Danvers, MA 01923
E-Mail: tlangford(at)abiomed.com
Phone: 978-882-8408
NPS-2567